Sargent Investment Group’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$369K Buy
5,875
+65
+1% +$4.53K 0.05% 184
2025
Q4
$386K Buy
+5,810
New +$376K 0.05% 185
2025
Q3
Sell
-11,835
Closed -$904K 150
2025
Q2
$904K Sell
11,835
-1,430
-11% -$112K 0.12% 109
2025
Q1
$906K Buy
+13,265
New +$1.08M 0.14% 100

Other funds holding DXCM

Sargent Investment Group's DXCM Position: Q1 2026 in Review

Sargent Investment Group increased its DexCom (DXCM) stake by 1.1% in Q1 2026, buying an estimated $4.53K and bringing the position to 5,875 shares worth $369K. The position accounts for 0.05% of the portfolio, ranked #184.

Sargent Investment Group first reported a position in DXCM in Q1 2025 and has held it in 4 quarters since. The position peaked at $906K in Q1 2025. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Sargent Investment Group held 5,875 shares of DexCom worth $369K as of Q1 2026.
  • Sargent Investment Group bought 65 DexCom shares in Q1 2026, an estimated $4.53K.
  • DexCom made up 0.05% of Sargent Investment Group's portfolio in Q1 2026, its #184 holding.
  • Sargent Investment Group first reported a position in DexCom in Q1 2025 and has held it in 4 quarters since.
  • Sargent Investment Group's DexCom position peaked at $906K in Q1 2025.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Sargent Investment Group's 13F filing for Q1 2026, filed 11 May 2026.